Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Chao

Showing results (761-770 of 1,184) with videos related to

Pageof 119
Sort By:
Journal of Medicinal Chemistry|September 20, 2008
Structure-guided design of N-phenyl tertiary amines as transrepression-selective liver X receptor modulators with anti-inflammatory activityEsther Y Chao, Justin A Caravella, Mike A Watson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 30, 2015
A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancerJ S Chen, C Hsu, N J Chiang, et al.
Journal of Synchrotron Radiation|May 5, 2021
Development of the Soft X-ray AGM-AGS RIXS beamline at the Taiwan Photon SourceA Singh, H Y Huang, Y Y Chu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2025
Germline-Somatic Interactions in BRCA-Associated Cancers: Unique Molecular Profiles and Clinical Outcomes Linking ATM to TP53 Synthetic EssentialityAli T Arafa, Siddhartha Yadav, Catherine H Marshall, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 17, 2018
Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinomaG K Abou-Alfa, S Qin, B-Y Ryoo, et al.
ESMO Open|August 20, 2022
Isatuximab plus atezolizumab in patients with advanced solid tumors: results from a phase I/II, open-label, multicenter studyM Simonelli, E Garralda, F Eskens, et al.
Oncoimmunology|August 16, 2019
Vaccinia-based oncolytic immunotherapy Pexastimogene Devacirepvec in patients with advanced hepatocellular carcinoma after sorafenib failure: a randomized multicenter Phase IIb trial (TRAVERSE)M Moehler, J Heo, H C Lee, et al.
Cancer|October 11, 2018
Treatment of childhood acute lymphoblastic leukemia with delayed first intrathecal therapy and omission of prophylactic cranial irradiation: Results of the TPOG-ALL-2002 studyTing-Chi Yeh, Der-Cherng Liang, Jen-Yin Hou, et al.
Pediatric Blood & Cancer|October 4, 2016
Treatment for childhood acute lymphoblastic leukemia in Taiwan: Taiwan Pediatric Oncology Group ALL-2002 study emphasizing optimal reinduction therapy and central nervous system preventive therapy without cranial radiationMeng-Ju Li, Hsi-Che Liu, Hsiu-Ju Yen, et al.
Scientific Reports|March 16, 2021
Treatment outcomes of pediatric acute myeloid leukemia: a retrospective analysis from 1996 to 2019 in TaiwanYung-Li Yang, Tang-Her Jaing, Shih-Hsiang Chen, et al.
Pageof 119

Showing results (761-770 of 1,184) with videos related to

Sort By:
Pageof 119
Journal of Medicinal Chemistry|September 20, 2008
Structure-guided design of N-phenyl tertiary amines as transrepression-selective liver X receptor modulators with anti-inflammatory activityEsther Y Chao, Justin A Caravella, Mike A Watson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 30, 2015
A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancerJ S Chen, C Hsu, N J Chiang, et al.
Journal of Synchrotron Radiation|May 5, 2021
Development of the Soft X-ray AGM-AGS RIXS beamline at the Taiwan Photon SourceA Singh, H Y Huang, Y Y Chu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2025
Germline-Somatic Interactions in BRCA-Associated Cancers: Unique Molecular Profiles and Clinical Outcomes Linking ATM to TP53 Synthetic EssentialityAli T Arafa, Siddhartha Yadav, Catherine H Marshall, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 17, 2018
Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinomaG K Abou-Alfa, S Qin, B-Y Ryoo, et al.
ESMO Open|August 20, 2022
Isatuximab plus atezolizumab in patients with advanced solid tumors: results from a phase I/II, open-label, multicenter studyM Simonelli, E Garralda, F Eskens, et al.
Oncoimmunology|August 16, 2019
Vaccinia-based oncolytic immunotherapy Pexastimogene Devacirepvec in patients with advanced hepatocellular carcinoma after sorafenib failure: a randomized multicenter Phase IIb trial (TRAVERSE)M Moehler, J Heo, H C Lee, et al.
Cancer|October 11, 2018
Treatment of childhood acute lymphoblastic leukemia with delayed first intrathecal therapy and omission of prophylactic cranial irradiation: Results of the TPOG-ALL-2002 studyTing-Chi Yeh, Der-Cherng Liang, Jen-Yin Hou, et al.
Pediatric Blood & Cancer|October 4, 2016
Treatment for childhood acute lymphoblastic leukemia in Taiwan: Taiwan Pediatric Oncology Group ALL-2002 study emphasizing optimal reinduction therapy and central nervous system preventive therapy without cranial radiationMeng-Ju Li, Hsi-Che Liu, Hsiu-Ju Yen, et al.
Scientific Reports|March 16, 2021
Treatment outcomes of pediatric acute myeloid leukemia: a retrospective analysis from 1996 to 2019 in TaiwanYung-Li Yang, Tang-Her Jaing, Shih-Hsiang Chen, et al.
Pageof 119